AP-165

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameAP-165
Drug Alias Namemelanocortin receptor 4 agonist (AcurePharma)MCR4 agonist (AcurePharma)AP-165
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMelanocortin receptor 4 agonists
TargetsMelanocortin receptor 4
Therapy Area/IndicationsDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySweden
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAcure Pharma AB
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAcure Pharma AB
Active IndicationsN/A
Inactive IndicationsDiabetes Mellitus, Type 2

Other Information

ATC CodeN/A
Related LinksN/A